Santé Ventures is a venture capital firm established in 2006by Kevin M. Lalande and Joe Cunningham. The firm is headquartered in Austin, Texas. As of June 2019, Santé Ventures has sold off its ownership in 22 companies and is managing its stakes in 17 companies. It prefers to fund companies operating in the life sciences field, at the early stage of development.
In 2011, Sante Ventures announced raising $139 million for their second venture capital fund for investing in healthcare and medical technology companies. The firms second fund received funding from 17 investors. Notable companies receiving investments from Sante Ventures second fund include: BAROnova, TVA Medical, and EndoStim.
On May 29, 2019 Sante Venture announced raising $250 million for their third venture capital fund which will focus on investing in healthcare and life science companies. The fund received commitments from more than 30 limited partners, most notably the Pennsylvania Public School Retirement System (PSERS). The fund will be used to make approximately 20-25 investments in primarily seed to series B stage startup companies.
The co-founder and managing partner of Sante Ventures, Kevin Lalande, made the following statements regarding the firms third investment fund:
We are grateful for the trust and confidence investors have placed in us with their capital. We are also pleased to have broadened our base of institutional limited partners with the addition of sovereign wealth funds, investors from Europe and Asia, and several new preeminent healthcare delivery systems. Over the last decade we have proven and continued to refine our unique portfolio strategy, which is designed to engineer the luck out of fund-level venture capital returns. Our multi-disciplinary investment team partners with exceptional entrepreneurs to build innovative companies with the potential to deliver better health outcomes at lower total cost, without relying on exits at unicorn valuations to generate attractive returns for our investors.
A company developing immunotoxins for the treatment of cancer
A biopharmaceutical company developing protein based therapeutics as a medical countermeasure for radiation exposure and chemical threats
A company developing therapies for managment of chronic low back pain
A company developing annuloplasty device for the treatment of cardiovascular disease
Baronova is a Goleta, California-based healthcare company.
A biopharmaceutical company developing therapeutics for rare diseases
Joel R. Lang
Documentaries, videos and podcasts